Successful treatment of hepatitis B-associated polyarteritis nodosa with a combination of lamivudine and conventional immunosuppressive therapy: a case report
Open Access
- 1 January 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 39 (1) , 106-108
- https://doi.org/10.1093/rheumatology/39.1.106
Abstract
Sir, Treatment of hepatitis B virus (HBV)-associated polyarteritis nodosa with immunosuppression is problematic due to possible enhancement of viral replication [1], which may also possibly worsen the vasculitis by enhancing viral antigenaemia.Keywords
This publication has 5 references indexed in Scilit:
- A One-Year Trial of Lamivudine for Chronic Hepatitis BNew England Journal of Medicine, 1998
- Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study.Gastroenterology, 1997
- Lamivudine Is Effective in Suppressing Hepatitis B Virus Dna in Chinese Hepatitis B Surface Antigen Carriers: A Placebo–Controlled TrialHepatology, 1997
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Deleterious Effect of Prednisolone in HBsAg-positive Chronic Active HepatitisNew England Journal of Medicine, 1981